AllianceBernstein’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.8M | Sell |
3,825,793
-97,012
| -2% | -$1.69M | 0.02% | 530 |
|
|
2025
Q1 | $49.3M | Buy |
3,922,805
+42,071
| +1% | +$529K | 0.02% | 590 |
|
|
2024
Q4 | $40.9M | Buy |
3,880,734
+3,807,074
| +5,168% | +$40.2M | 0.01% | 656 |
|
|
2024
Q3 | $1.07M | Hold |
73,660
| – | – | ﹤0.01% | 2290 |
|
|
2024
Q2 | $627K | Buy |
73,660
+14,490
| +24% | +$123K | ﹤0.01% | 2539 |
|
|
2024
Q1 | $605K | Sell |
59,170
-3,620
| -6% | -$37K | ﹤0.01% | 2501 |
|
|
2023
Q4 | $344K | Hold |
62,790
| – | – | ﹤0.01% | 2783 |
|
|
2023
Q3 | $237K | Buy |
62,790
+38,010
| +153% | +$144K | ﹤0.01% | 2893 |
|
|
2023
Q2 | $166K | Buy |
+24,780
| New | +$166K | ﹤0.01% | 3018 |
|
|
2021
Q3 | – | Sell |
-7,300
| Closed | -$225K | – | 3320 |
|
|
2021
Q2 | $225K | Buy |
+7,300
| New | +$225K | ﹤0.01% | 3111 |
|